Advertisement

Biological e vaccine News

alt
The Drugs Controller General of India (DGCI) on Wednesday authorized Hyderabad-based Biological E. Ltd to conduct Phase 2 and 3 clinical trials for its anti-COVID vaccine named Corbevax on children aged 5 to 18 years with certain conditions.






Loading...
english news
NEWS ON ONE CLICK